mRNA Archives

Healthcare Industry News Weekly Wrap-Up: February 16, 2024

// Biotech and Pharma Therapeutics Sage Touts Strong Launch for Postpartum Depression Drug Zurzuvae February 15, 2024 / Depression / Postpartum / Women’s Health / Sage Therapeutics Despite launching with just days left in 2023, Sage Therapeutics’ postpartum depression therapy...

February 16, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: October 20, 2023

// Biotech and Pharma Therapeutics Bayer opens California plant to make cell therapies October 10, 2023 / Bayer / California / Cell Therapies / Parkinson’s The new facility is the latest investment from Bayer into cell and gene therapy. Bayer has...

October 20, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: August 25, 2023

// Biotech and Pharma Therapeutics Pfizer drops sickle cell disease collab with Syros inherited from GBT takeover July 24, 2023 / Pfizer / Syros Pharmaceuticals / Sickle Cell Disease / Beta Thalassemia At tail-end of 2019, GBT agreed to pay...

August 25, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: June 23, 2023

// Biotech and Pharma Therapeutics Eli Lilly’s Mounjaro is primed to overtake Novo Nordisk’s popular diabetes and obesity duo: report June 19, 2023 / Mounjaro / Eli Lilly / GlobalData / Novo Nordisk Approved in May of last year for...

June 23, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: May 12, 2022

// Biotech and Pharma Therapeutics Boehringer Ingelheim to surf with Melbourne-based biotech in $181M neuropsychiatric therapy deal May 5, 2023 / Boehringer Ingelheim / Australia / Psychiatric Drugs / Development deals The German pharma will work with the small Melbourne-based...

May 12, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 16, 2022

// Biotech and Pharma Therapeutics Eli Lilly touts early demand for high-stakes diabetes launch Mounjaro: analysts September 14, 2022 / Mounjaro / Tirzepatide / Type 2 Diabetes After snaring approval in May, Eli Lilly’s closely watched diabetes med tirzepatide—now christened...

September 16, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 9, 2021

// Biotech and Pharma Therapeutics Philip Morris takes control of Vectura amid pushback against acquisition September 17, 2021 / Philip Morris / Vectura / Acquisition The attempt to buy Vectura has been more challenging and fractious than the other deals,...

September 9, 2021

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: August 5, 2021

// Biotech and Pharma Therapeutics Magnetic pills deliver insulin to refill implanted reservoir August 24, 2021 / Diabetes / Implantable Drug Delivery / Implantable Pump / Insulin It is now more than 40 years since the first diabetic received an...

August 5, 2021

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: July 22, 2021

// Biotech and Pharma Therapeutics New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Biosimilar July 29, 2021 / Diabetes / FDA / Biologics The U.S. Food and Drug Administration (FDA) approved Viatris and Biocon Biologics’ Semglee (insulin glargine-yfgn...

July 22, 2021

Tag: mRNA

Healthcare Industry News Weekly Wrap-Up: February 16, 2024

Healthcare Industry News Weekly Wrap-Up: October 20, 2023

Healthcare Industry News Weekly Wrap-Up: August 25, 2023

Healthcare Industry News Weekly Wrap-Up: June 23, 2023

Healthcare Industry News Weekly Wrap-Up: May 12, 2022

Healthcare Industry News Weekly Wrap-Up: September 16, 2022

Healthcare Industry News Weekly Wrap-Up: September 9, 2021

Healthcare Industry News Weekly Wrap-Up: August 5, 2021

Healthcare Industry News Weekly Wrap-Up: July 22, 2021

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy⁺

About Vault

Tag: mRNA

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy+

About Vault

Strategy⁺